Found 91 articles for: "seborrheic dermatitis"
CLINICAL TRIAL REVIEW
October 2011 | Volume 10 | Issue 10 | Features | 1216 | Copyright © October 2011
Clinical Trial Review is a JDD department designed to provide physicians with information on drugs and devices undergoing clinical testing. It is our goal to inform the reader of the status of select ...
Read MoreManifestations and Treatment of Cutaneous Lupus Erythematosus (Part I of II)
October 2011 | Volume 10 | Issue 10 | Features | 1212 | Copyright © October 2011
Treatment of Interdigital Tinea Pedis: Once-Daily Therapy With Sertaconazole Nitrate
October 2011 | Volume 10 | Issue 10 | Original Article | 1135 | Copyright © October 2011
The treatment of cutaneous fungal infections has been shown to be directly affected by the extent of patients' adherence to therapy regimens that ar...
Read MoreCentral Serous Chorioretinopathy Associated With Topical Corticosteroids in a Patient With Psoriasis
August 2011 | Volume 10 | Issue 8 | Case Reports | 918 | Copyright © August 2011
Background: Central serous chorioretinopathy (CSC), also known as central serous retinopathy (CSR), is a visual impairment, often temporary, ...
Read MoreAn Open-label Study of the Safety and Efficacy of Sertaconazole Nitrate in the Treatment of Seborrheic Dermatitis
August 2011 | Volume 10 | Issue 8 | Original Article | 895 | Copyright © August 2011
Objectives: To demonstrate the efficacy and evaluate the safety of sertaconazole nitrate cream 2% in the treatment of seborrheic dermatitis (SD).
Design: Single-center, open-label...
Read MoreScalp Hyperkeratosis and Alopecia in Children of Color
May 2011 | Volume 10 | Issue 5 | Original Article | 511 | Copyright © May 2011
Background: Scalp hyperkeratosis and/or alopecia are common pediatric dermatologic findings. In Caucasian children, scalp hyperkeratosis o...
Read MoreClinical Trial Review
March 2011 | Volume 10 | Issue 3 | Original Article | 312 | Copyright © March 2011
Clinical Trial Review is a JDD department designed to provide physicians with information on drugs and devices undergoing clinical testing. It is our goal to inform the reader of the status of select ...
Read MoreFacial Seborrheic Dermatitis: A Report on Current Status and Therapeutic Horizons
February 2009 | Volume 8 | Issue 2 | Original Article | 125 | Copyright © February 2009
Seborrheic dermatitis, characterized by erythema and/or flaking or scaling in areas of high sebaceous activity, affects up to 5% of the US population and often appears in conjunction with othe...
Read MoreA Novel Foam Formulation of Ketoconazole 2% for the Treatment of Seborrheic Dermatitis on Multiple Body Regions
October 2007 | Volume 6 | Issue 10 | Original Article | 1001 | Copyright © October 2007
Background: A novel topical foam formulation of ketoconazole has been developed for use on the scalp, body, and face. Objective: To evaluate the efficacy and safety of twice-daily treatment with keto...
Read MoreEfficacy and Safety of a New Once-Daily Topical Ketoconazole 2% Gel in the Treatment of Seborrheic Dermatitis: A Phase III Trial
July 2006 | Volume 5 | Issue 7 | Original Article | 646 | Copyright © July 2006
Background: The first gel formulation of ketoconazole has been tested in 2-week treatment courses. Objective: To evaluate the efficacy and safety of a new, once-daily, 2-week ketoconazole 2% gel trea...
Read MoreSeborrheic Dermatitis of the Scalp: Etiology and Treatment
March 2004 | Volume 3 | Issue 2 | Original Article | 155 | Copyright © March 2004
Seborrheic dermatitis is a common chronic infection of the lipid-rich areas of skin. While seborrheic dermatitis has been a recognized clinical entity for decades, its etiology is far from clear. Earl...
Read More